Résumé
En 2011, le prix Nobel de physiologie ou de médecine était décerné à Ralph Steinman pour sa découverte des cellules dendritiques, éléments clés de l’immunité adaptative, et à Jules Hoff man et Bruce Beutler pour leurs travaux sur les récepteurs cellulaires de l’immunité innée. Cette reconnaissance des deux volets de l’immunité est réminiscente du prix Nobel accordé en 1908 à Élie Metchnikoff et à Paul Ehrlich, en récompense respectivement de leurs travaux sur l’immunité cellulaire et l’immunité humorale. En effet, l’immunité est classée en deux grands domaines : l’immunité innée et l’immunité adaptative, toutes deux impliquant des acteurs cellulaires et des facteurs humoraux. L’immunité adaptative, antérieurement qualifiée d’immunité spécifique, est nécessaire pour le contrôle des infections de longue durée et pour la mise en place d’une mémoire immunologique sur laquelle s’appuie la vaccination. Longtemps, l’immunité innée fut qualifiée d’ « immunité non spécifique », une formulation négative qui reflétait alors le faible intérêt pour ce volet de l’immunologie. Mais ces dernières années, ce domaine a fait l’objet d’un renouveau, en particulier, suite à la découverte des Toll-like receptors (TLR) et des Nod-like receptors (NLR). Ces récepteurs (Pattern recognition receptors, PRR) reconnaissent spécifiquement des déterminants microbiens nommés pathogen-associated molecular patterns (PAMP). Par conséquent, le concept d’immunité non spécifique n’est plus approprié pour définir l’immunité innée.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Références
Janeway CA Jr (1989) Approaching the asymptote? Évolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 54: 1–13
Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991–1045
von Behring E, Kitasato S (1890) On the acquisition of immunity against diphtheria and tetanus in animals (German). Dtsch Med Wochenschr 16: 1145–8
Ehrlich P (1897) Die Wertbemessung des Diphterieheilserums und deren theoretische Grundlagen. Klinisches Jahrbuch 6: 299–326
Coutinho A, Kazatchkine MD, Avrameas S (1995) Natural autoantibodies. Curr Opin Immunol 7: 812–8
Vollmers HP, Brandlein S (2006) Natural IgM antibodies: the orphaned molecules in immune surveillance. Adv Drug Deliv Rev 58: 755–7
Ochsenbein AF, Zinkernagel RM (2000) Natural antibodies and complement link innate and acquired immunity. Immunol Today 21: 624–30
Boes M, Prodeus AP, Schmidt T, et al. (1998) A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188: 2381–6
Guo RF, Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23: 821–2
Prodeus AP, Zhou X, Maurer M, et al. (1997) Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390: 172–5
Cavaillon JM (2011) The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff. J Leukoc Biol 90: 413–24
Wright AE, Douglas SR (1903) An experimental investigation on the role of the blood fluids in connection with phagocytosis. Proc R Soc London 72,: 357–70
de Cathelineau AM, Henson PM (2003) The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem 39: 105–17
Brinkmann V, Reichard U, Goosmann C, et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663): 1532–5
Clark SR, Ma AC, Tavener SA, et al. (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13: 463–946
Dziarski R, Gupta D (2010) Mammalian peptidoglycan recognition proteins (PGRPs) in innate immunity. Innate Immun 16: 168–74
Schroder JM, Harder J (1999) Human beta-defensin-2. Int J Biochem Cell Biol 31: 645–51
Harder J, Bartels J, Christophers E, Schroder JM (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707–13
Abraham SN, St John AL (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10: 440–52
Echtenacher B, Männel DN, Hültner L (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75–7
Malaviya R, Twesten NJ, Ross EA, et al. (1996) Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156: 1490–6
Miller JF, Brunner KT, Sprent J, et al. (1971) Thymus-derived cells as killer cells in cell-mediated immunity. Transplant Proc 3: 915–7
Kiessling R, Klein E, Wigzell H (1975) “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5(2): 112–7
MacFarlan RI, Burns WH, White DO (1997) Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells. J Immunol
Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM (2012) Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med 18: 270–85
Freitas A, Alves-Filho JC, Victoni T, et al. (2009) IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol 182: 7846–54
Flierl MA, Rittirsch D, Gao H, et al. (2008) Adverse functions of IL-17A in experimental sepsis. FASEB J 22: 2198–2205
Lemaitre B, Nicolas E, Michaut L, et al. (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal. Cell 86: 973–83
Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394–7
Poltorak A, He X, Smirnova I, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085–8
Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140: 805–20
Girardin SE, Boneca IG, Carneiro LA, et al. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584–7
Girardin SE, Boneca IG, Viala J, et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869–72
Sabbah A, Chang TH, Harnack R, et al. (2009) Activation of innate immune antiviral responses by Nod2. Nat Immunol 10: 1073–80
Silva GK, Gutierrez FR, Guedes PM, et al. (2010) Nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J Immunol 184: 1148–52
Shigeoka AA, Kambo A, Mathison JC, et al. (2010) Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 184: 2297–2304
Schroder K, Tschopp J (2010) The inflammasomes. Cell 140: 821–32
Lee BH, Inui D, Suh GY, et al. (2012) Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multicentered prospective observational study. Crit Care 16: R33
Schortgen F, Clabault K, Katsahian S, et al. (2012) Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med In press
Welch WH (1888) Cartwright lectures. The general pathology of fever. Boston Med Surg J 118: 413–21
Legrand EK (1990) Endotoxin as an alarm signal of bacterial invasion: current evidence and implications. J Am Vet Med Assoc 197: 454–6
Audibert F, Chedid L, Lefrancier P, et al. (1977) Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). Ann Immunol (Paris) 128C: 653–61
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 Springer-Verlag Paris
About this chapter
Cite this chapter
Cavaillon, JM. (2013). Les défenses de l’organisme et immunité innée. In: Infectiologie en réanimation. Références en réanimation. Collection de la SRLF. Springer, Paris. https://doi.org/10.1007/978-2-8178-0389-0_1
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0389-0_1
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0388-3
Online ISBN: 978-2-8178-0389-0
eBook Packages: MedicineMedicine (R0)